
LRRK2 Knockout in A549 Cell Line (Human)
CRISPR knockout immortalized cell lines — pools or clones with guaranteed editing efficiency, optimized across more than 500 human cell lines and delivered assay-ready.
Fast, Reliable CRISPR Knockout Pools and Clones. Consistent knockouts you can trust leveraging our XDel multi-guide designs with 98% average editing efficiency. NGS-verified with QC report, assay ready cells shipped in as fast as 2 weeks. *Please contact your EditCo representative for academic pricing.
LRRK2 XDel design
ENSG00000188906This gene is a member of the leucine-rich repeat kinase family and encodes a protein with an ankryin repeat region, a leucine-rich repeat (LRR) domain, a kinase domain, a DFG-like motif, a RAS domain, a GTPase domain, a MLK-like domain, and a WD40 domain. The protein is present largely in the cytoplasm but also associates with the mitochondrial outer membrane. Mutations in this gene have been associated with Parkinson disease-8. [provided by RefSeq, Jul 2008]
- Guides designed
- 3
- Cuts canonical
- Yes
- Coding seq. cut
- 98%–100%
- CCDS cut
- 2 of 2
- Earliest exon cut
- Exon 1
- Off-target genes
- None
Cancer cell line · Male · 58Y · lung
This line vs. all DepMap-profiled lines for LRRK2.
Common questions about LRRK2 in A549
- Is LRRK2 essential in A549?
- No. In DepMap's CRISPR knockout screens of A549 (ACH-000681), LRRK2 has a gene effect score of −0.02, and a 0.02 probability that the line depends on it. A score near 0 means knocking out LRRK2 has little effect on the line's growth.
- Is LRRK2 expressed in A549?
- Yes, at a low level. In DepMap's RNA sequencing of A549 (ACH-000681), LRRK2's canonical transcript, ENST00000298910, is expressed at about 3.3 TPM.
- Which LRRK2 transcripts does the knockout cut?
- The XDel guides cut 18 LRRK2 transcripts, including the canonical transcript ENST00000298910. They cut all 2 of its CCDS protein-coding transcripts. DepMap measured 4 of the cut transcripts in A549.
Where does the A549 data come from? From DepMap, the Broad Institute's Cancer Dependency Map, which profiles A549 (ACH-000681).
ACH-000681Popular targets by cell line
Data
XDel Knockout Cells Enable gene-edited knockout cell pools and clones - Guaranteed and Delivered in 4 Weeks (Pools) or 10 Weeks (Clones)Figure 1. A) Four membrane proteins were knocked out in K562 cells using XDel technology, following EditCo Bio’s proprietary workflow. Protein levels were assessed via flow cytometry at four time points: days 3, 7, 14, and 21 post-transfection, and compared to negative controls (non-edited cells or cells electroporated with Cas9 only). Membrane protein depletion remained stable over time, and cell viability was consistently high (>90%) across all samples. B) Representative flow cytometry plots showing protein levels for CD46 and CD59 in XDel knockout pools at 21 days post-editing.